関連する実験動画

Updated: Sep 9, 2025

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.3K

転移性乳がんにおけるAnti- Her2治療パターンの実態データは,治療不足を示唆している

Kathrine F Vandraas1,2,3, Sarah Hjorth1,3, Cassia B Trewin-Nybråten4

  • 1Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.

International journal of cancer
|September 2, 2025
PubMed
まとめ

HER2+転移性乳がん (mBC) に対する抗HER2療法が推奨値と一致することを実用データから示しています. しかし,多くの患者,特に併発性疾患を持つ高齢者は,標的治療を受けなかったため,治療不足の可能性を示唆しています.

キーワード:
HER2+ 転移性乳がん人口ベースのコホート現実世界のデータ脆弱な患者グループ

さらに関連する動画

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.9K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.2K

関連する概念動画

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K